[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363303-105":59,"doc-detail-363303-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","clinical-relevance-of-usp44-expression-and-dna-methylation-status-in-breast-cancer-original-research","Clinical Relevance of USP44 Expression and DNA Methylation Status in Breast Cancer - Original Research","","Study evaluates ubiquitin-specific peptidase 44 (USP44) as a candidate biomarker and therapeutic target in breast cancer by characterizing its expression and DNA methylation in cell lines, breast tumor tissues, and circulating tumor DNA. USP44 expression was measured by quantitative reverse transcription-polymerase chain reaction and immunohistochemistry, while methylation was assessed by pyrosequencing in tissues and methylation-specific PCR in ctDNA and cell lines. USP44 promoter status and distinct clinicopathological associations are identified, while ctDNA and tissue methylation show limited correlation, supporting complex epigenetic regulation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/clinical-relevance-of-usp44-expression-and-dna-methylation-status-in-breast-cancer-original-research/363303/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/clinical-relevance-of-usp44-expression-and-dna-methylation-status-in-breast-cancer-original-research/363303.png","ImageObject",300,407,{"name":92,"@type":93},"Stanley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study purpose regarding USP44 in breast cancer?","Question",{"text":112,"@type":113},"To determine how USP44 expression and DNA methylation are regulated in breast cancer and whether they associate with clinicopathological features across cell lines, tissues, and circulating tumor DNA.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were USP44 expression and DNA methylation measured?",{"text":117,"@type":113},"USP44 expression was assessed by quantitative reverse transcription-polymerase chain reaction in cell lines and immunohistochemistry in breast tissues. DNA methylation was analyzed by pyrosequencing in tissue samples and by methylation-specific PCR in ctDNA and cell lines.",{"name":119,"@type":110,"acceptedAnswer":120},"What key findings link USP44 to clinicopathological characteristics?",{"text":121,"@type":113},"USP44 expression was highest in the triple-negative cell line MDA-MB-231 with an unmethylated USP44 promoter, and USP44 methylation frequency in tissues associated with progesterone receptor positivity, HER2 overexpression, and breast cancer molecular subtype.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},363303,1790657903,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336477405376,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Breast Cancer: Targets and Therapy  \n Open Access Full Text Article  \nORIGINAL RESEARCH  \nClinical Relevance of USP44 Expression and DNA Methylation Status in Breast Cancer Cell Lines, Tumor Tissues, and Circulating Tumor DNA  \nKee Tae Park 1 , Na-Rang Lee 1 , 2 , Young Ju Jeong 1 , 2  \n1Department of Surgery, Daegu Catholic University Hospital, Daegu, Republic of Korea; 2Department of Surgery, School of Medicine, Daegu Catholic University, Daegu, Republic of Korea  \nCorrespondence: Young Ju Jeong, Department of Surgery, School of Medicine, Daegu Catholic University,(42471) 33, Duryugongwon-ro 17-gil, Namgu, Daegu, Republic of Korea, Tel +82-53-650-4875, Fax +82-53-624-7185, [Email yjjeong@cu.ac.kr](Email yjjeong@cu.ac.kr)  \n\n| Purpose: Ubiquitin-specific peptidase 44 (USP44), a deubiquitinating enzyme involved in chromosomal stability and cell cycle control, has been proposed as a potential biomarker and a therapeutic target in various cancers. However, its expression and epigenetic regulation in breast cancer remain understudied. This study investigated USP44 expression and DNA methylation status in breast cancer cell lines, breast cancer tissues and circulating tumor DNA (ctDNA), and their association with clinicopathological features. Patients and Methods: USP44 expression was assessed by quantitative reverse transcription-polymerase chain reaction in cell lines, and by immunohistochemistry in breast tissues including 33 breast cancers and 13 benign breast lesions. DNA methylation status of USP44 was analyzed by pyrosequencing in tissue samples, and by methylation-specific PCR in ctDNA and cell lines. Associations with clinicopathological parameters were statistically evaluated.\u003Cbr>Results: USP44 expression varied among breast cancer cell lines, with highest levels in the triple-negative breast cancer MDA-MB-231, corresponding to an unmethylated USP44 promoter. The positive expression rate of USP44 was 69.7% in breast cancer tissues. USP44 expression in breast cancer tissues did not differ significantly with that of benign tissues, but was associated with age ≥60 years and inversely correlated with presence of fibrotic focus. Mean methylation frequency was 43.7 ± 13.2% in breast cancer tissues, and ctDNA methylation was detected in 65.7% of breast cancer patients. Methylation status in ctDNA did not correlate with tissue methylation. Higher tissue USP44 methylation frequency was significantly associated with progesterone receptor positivity, HER2 overexpression and molecular subtype of breast cancer.\u003Cbr>Conclusion: USP44 gene expression and DNA methylation status were associated with distinct clinicopathological features in breast cancer. These findings suggest complex epigenetic regulation of USP44 and its biological relevance in breast cancer. Given the limited sample size and exploratory design, further studies in larger independent cohorts are required to validate the potential role of USP44 asan epigenetic biomarker.\u003Cbr>Keywords: breast cancer, USP44, DNA methylation, epigenetic biomarker |\n| --- |\n| Introduction\u003Cbr>Breast cancer remains a leading cause of cancer morbidity and mortality worldwide, reflecting marked molecular heterogeneity.1 In addition to genetic alterations, epigenetic changes such as DNA methylation play a crucial role in breast tumorigenesis and progression and are increasingly leveraged as biomarkers for diagnosis, subtyping, and prognostic stratification.2,3\u003Cbr>Ubiquitin-specific peptidase 44 (USP44) belongs to the deubiquitinating enzyme family involved in the regulation of protein turnover and cell cycle progression.4 USP44 has been implicated in chromosome segregation, spindle checkpoint control, and genomic stability.4 USP44 plays an important role in maintaining genomic integrity through regulation of the spindle assembly checkpoint by controlling the activity of the anaphase-promoting complex/cyclosome.4 Loss of USP44 activity may promote chromosomal instability and aneuploidy, which are ke","cbCaiqMA5yYnb9DD","https://ap.wps.com/l/cbCaiqMA5yYnb9DD","pdf",1549196,11,"English","# Purpose\n# Patients and Methods\n## USP44 expression assessment\n## DNA methylation assessment\n# Results\n# Conclusion\n# Introduction\n## Breast cancer heterogeneity and epigenetics\n## Biological role of USP44","[{\"question\":\"What was the study purpose regarding USP44 in breast cancer?\",\"answer\":\"To determine how USP44 expression and DNA methylation are regulated in breast cancer and whether they associate with clinicopathological features across cell lines, tissues, and circulating tumor DNA.\"},{\"question\":\"How were USP44 expression and DNA methylation measured?\",\"answer\":\"USP44 expression was assessed by quantitative reverse transcription-polymerase chain reaction in cell lines and immunohistochemistry in breast tissues. DNA methylation was analyzed by pyrosequencing in tissue samples and by methylation-specific PCR in ctDNA and cell lines.\"},{\"question\":\"What key findings link USP44 to clinicopathological characteristics?\",\"answer\":\"USP44 expression was highest in the triple-negative cell line MDA-MB-231 with an unmethylated USP44 promoter, and USP44 methylation frequency in tissues associated with progesterone receptor positivity, HER2 overexpression, and breast cancer molecular subtype.\"}]","Clinical Relevance of USP44 Expression and DNA Methylation Status in Breast Cancer - Original Research | PDF",1790150696,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c6039c777339a4f796c2c2b077ad2e52.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/11a283f4198d69c52525735216bd1aae.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9920dc09d41d21a7677d3be4b5e8edf3.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/332269256a9973e7c40e42d9ee3868dc.webp",980,1268]